GlassScriptPhysician profile
Adaobi Udemba
NPI 1154753630
$3,481.73
in general payments reported to CMS, 2019-2025
7 companies · $865 in 2025
The $865 reported for 2025 was more than what 85% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $646 · 2022: $378 · 2023: $1,200 · 2024: $394 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,886 · Travel and Lodging: $555 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,885.62 |
| Travel and Lodging | $554.64 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Relievant Medsystems, INC. | $875.40 | 2023 | Intracept |
| Boston Scientific Corporation | $799.48 | 2021-2024 | Intracept |
| Djo, LLC | $695.56 | 2024-2025 | Cmf |
| Mml US, INC. | $510.01 | 2022-2025 | Reactiv8 |
| Depuy Synthes Sales INC. | $248.43 | 2021-2022 | |
| Orthofix Medical, INC. | $179.42 | 2021-2023 | Spinal-Stim, Cervical-Stim |
| Medtronic, INC. | $173.43 | 2025 | Inceptiv, Synchromedii |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adaobi Udemba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.